688677 Qingdao Novelbeam Technology
- 39.70
- -1.03-2.53%
Qingdao Novelbeam Technology News
Haitai Xinguang (688677.SH): Cumulatively repurchased 0.611% of shares, the company completed the repurchase.
Guolonghui November 4th | Haitai Xinguang (688677.SH) announced that as of the disclosure date of this announcement, the company has completed the repurchase. Qingdao Haitai Xinguang Technology Co., Ltd. repurchased 737,000 shares of the company through the Shanghai Stock Exchange trading system by means of centralized competitive bidding, accounting for 0.6110% of the total share capital of 120,614,000 shares of the company. The highest repurchase price was 40.75 yuan/share, the lowest price was 28.89 yuan/share, and the total amount of funds paid was RMB 26,109,622.58 (excluding stamp duty, transaction commission, and other transaction fees).
Haitai Xinguang (688677): Short-term pressure in 24Q3, expected improvement in shipments in Q4.
Event: The company released its third quarter report for 2024, with revenue of 0.32 billion yuan (-15.3%) for the first three quarters; net income attributable to the parent company of 0.097 billion yuan (-17.6%). Among them, Q3 revenue was 0.098 billion yuan (-9.4%).
Haitai Xinguang (688677): Q3 revenue continues to decline, Q4 shipments may recover.
Investment Highlights The company released the third quarter report of 2024, with revenue of 0.32 billion yuan for 2024 Q1-3, a year-on-year decrease of 15.3%; net income attributable to the parent company of 0.097 billion yuan, a year-on-year decrease of 17.6%. Among them, Q3 revenue is 0.98
Haitai Xinguang (688677): Short-term performance recovery can be expected due to the impact of customer order cycle.
Event: On October 25, the company released the third quarter report of 2024, achieving revenue of 0.319 billion yuan in the first three quarters of 2024, a year-on-year decrease of 15.30%; net income attributable to the parent company was 0.097 billion yuan, a year-on-year decrease.
Haitai Xinguang 2024 Third Quarter Report
Haitai Xinguang (688677.SH) disclosed its performance for the first three quarters, with a net income of 97.396 million yuan, a year-on-year decrease of 17.60%.
Haitai Xingguang (688677.SH) released the quarterly report for the first three quarters of 2024, during the reporting period the company achieved revenue...
NovelBeam Technology Names CFO; Shares Slump 11%
Haitai Xinguang (688677): The light of domestic endoscopes, waiting quietly for the recovery of overseas orders.
Investment Highlights: The company is the sole supplier of fluorescent endoscopes for Stryker Corp: HaiTaiXinGuang was established in 2003, mainly engaged in the research and development, production, and sales of medical endoscopes as well as optical products. The company is committed to exploring the integration of optical technology with medicine, industry, and
Haitai Xinguang (688677.SH): Since July of this year, it has been accepting endoscope orders from customers in the USA.
On September 19, Gelonghui stated on the investor interaction platform that Haitai Xinguang (688677.SH) has indicated that its Nevada subsidiary in the USA has been certified by American clients. It has been accepting endoscope orders from American clients since July this year. The progress of overseas business is proceeding as usual.
Express News | Haitai Xinguang: Ms. Zheng Jinlan was elected as the employee representative supervisor of the fourth session of the Board of Supervisors.
Express News | Star market closing review: SSE Science and Technology Innovation Board 50 Index fell 0.40%, semiconductor sector showed mixed gains and losses.
Haitai Xinguang (688677.SH): Cumulative repurchase of 0.6110% of the company's shares
On September 2, Guolonghui announced that as of August 31, 2024, Qingdao Haitai Xinguang Technology Co., Ltd. repurchased 737,000 shares of the company's stock through the Shanghai Stock Exchange trading system through centralized bidding trading, accounting for 0.6110% of the company's total share capital of 120,614,000 shares. The highest price of the repurchase transaction was 40.75 yuan per share, and the lowest price was 28.89 yuan per share. The total amount paid was RMB 26,109,622.58 (excluding stamp duty, trading commissions, and other transaction costs).
Haitai Xinguang (688677) 2024 Interim Report Review: Temporary performance pressure caused by customer inventory reduction, with high growth in overall sales revenue.
Company released its 2024 interim report, with a revenue of 0.22 billion yuan (-17.70%) and a net income attributable to the parent company of 0.071 billion yuan (-21.02%), and a non-GAAP net income of 0.065 billion yuan (-24.55%). 2
Express News | 158 companies received institutional research.
Express News | 121 companies received institutional research
Express News | 115 companies were surveyed by institutions, with Hangzhou Hikvision Digital Technology being the most popular.
Express News | 101 companies have been surveyed by institutions.
Express News | Star market closing review: medical instrument sector led the decline, while semiconductor and software sectors performed poorly throughout the day.
Express News | The social security fund holds 15 Star Market stocks: 5 new stocks and 2 shareholding stocks.
Haitai Xinguang (688677): The purchasing pace of major customers slows down, waiting for the level of shipments to recover.
Event: The company released its 2024 semi-annual report, achieving a revenue of 0.22 billion yuan (-17.7% YoY), a net income attributable to shareholders of 0.071 billion yuan (-21.0% YoY), and a non-GAAP net income attributable to shareholders of 0.065 billion yuan.
Analysis
Price Target
No Data
No Data